Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Neovascularization (NV) of the cornea can disrupt visual function, causing ocular diseases, including blindness. Therefore, treatment of corneal NV has a high public health impact. Epigalloccatechin-3-gallate (EGCG), presenting antiangiogenesis effects, was chosen as an inhibitor to treat human vasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Che-Yi, Wang, Ming-Chen, Miyagawa, Takuya, Chen, Zhi-Yu, Lin, Feng-Huei, Chen, Ko-Hua, Liu, Guei-Sheung, Tseng, Ching-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221810/
https://www.ncbi.nlm.nih.gov/pubmed/28115846
http://dx.doi.org/10.2147/IJN.S114754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221810/
https://www.ncbi.nlm.nih.gov/pubmed/28115846
http://dx.doi.org/10.2147/IJN.S114754

Ejemplares similares